These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 84550)

  • 1. [Effect of S-adenosyl-L-methionine on the cerebral and peripheral metabolism of L-dopa].
    Bidard JN; Fonlupt P; Cronenberger L; Pacheco H
    Arch Int Physiol Biochim; 1978 Oct; 86(4):715-24. PubMed ID: 84550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of S-adenosyl-L-methionine on catecholaminergic central function.
    Losada ME; Rubio MC
    Eur J Pharmacol; 1989 Apr; 163(2-3):353-6. PubMed ID: 2566505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of noradrenaline O-methylation in rat brain induced by L-dopa. Reversal effect of S-adenosyl-L-methionine.
    Stramentinoli G; Catto E; Algeri S
    J Pharm Pharmacol; 1980 Jun; 32(6):430-1. PubMed ID: 6106679
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
    Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
    Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
    Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of 3H-dopa for studying cerebral catecholamine metabolism.
    Persson T; Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1968; 26(4):363-72. PubMed ID: 5755483
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of halothane on catecholamine metabolism in the brain stem of rats].
    Schulte J
    Arzneimittelforschung; 1976; 26(3):324-7. PubMed ID: 989321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of amitriptyline, desipramine and imipramine on the vivo brain synthesis of 3H-noradrenaline from 3H-L-dopa in the rat.
    Nielsen M; Eplov L; Scheel-Krüger J
    Psychopharmacologia; 1975; 41(3):249-54. PubMed ID: 1098088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of monoamines into central neurones and the blood-brain barrier in the infant rat.
    Loizou LA
    Br J Pharmacol; 1970 Dec; 40(4):800-13. PubMed ID: 5495178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study.
    Horne MK; Cheng CH; Wooten GF
    Pharmacology; 1984; 28(1):12-26. PubMed ID: 6701184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
    Melega WP; Luxen A; Perlmutter MM; Nissenson CH; Phelps ME; Barrio JR
    Biochem Pharmacol; 1990 Jun; 39(12):1853-60. PubMed ID: 2112915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms.
    Crowell BG; Benson R; Shockley D; Charlton CG
    Behav Neural Biol; 1993 May; 59(3):186-93. PubMed ID: 8503824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.
    Buu NT; Lussier C
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):563-8. PubMed ID: 2748880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
    Storch A; Blessing H; Bareiss M; Jankowski S; Ling ZD; Carvey P; Schwarz J
    Mol Pharmacol; 2000 Mar; 57(3):589-94. PubMed ID: 10692500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
    Weiss BF; Roel LE; Munro HN; Wurtman RJ
    Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion of 3, 4-dihydroxyphenylalanine and deuterated 3, 4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain.
    Edwards DJ; Rizk M
    J Neurochem; 1981 May; 36(5):1641-7. PubMed ID: 6165806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa.
    Charlton CG; Crowell B
    Pharmacol Biochem Behav; 1992 Oct; 43(2):423-31. PubMed ID: 1359575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.